ArticleThe open respiratory medicine journal2025
Malignant Potential of Endobronchial Glomangioma: A Case Report of an Unpredictable Diagnosis and Unexpected Outcome.
Article in The open respiratory medicine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glomus tumors are neoplasms typically arising from the glomus body in the skin or subcutaneous tissue. They are rarely found in visceral organs, including the respiratory tract. Glomangioma is a vascular variant, and its pulmonary subtype is challenging to predict due to the absence of specific symptoms or distinctive radiological features. While most glomangiomas are benign, in rare cases, they can exhibit aggressive clinical and histological characteristics, leading to severe conditions. Case presentation: We report a case of malignant endobronchial glomangioma in a patient presenting with hemoptysis and atypical chest pain. Chest computed tomography (CT) revealed an endobronchial tumor in the left distal main stem bronchus, partially obstructing the lumen. The patient was clinically diagnosed with suspected metastatic lung cancer and was scheduled for bronchoscopy and biopsy. During the biopsy, a rounded, bulging mass was partially removed; however, significant intraoperative bleeding occurred, necessitating the formation of an intentional blood clot. Ongoing bleeding and airway necessitated emergency pneumonectomy after 24 hours. Unfortunately, the patient experienced cardiac arrest postoperatively and died. Pathological examination revealed a mass with prominent vascular components lined by endothelial cells, with immunohistochemistry showing positivity only for smooth muscle actin, supporting the diagnosis of glomangioma. Conclusion: Although difficult to diagnose clinically prior to biopsy, malignant endobronchial glomangioma should be considered in certain patient populations due to its specific outcomes and complications. Preventive measures and targeted interventions should be implemented to manage iatrogenic bleeding complications associated with biopsy procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.